Erythematous plaques with zosteriform distribution in a patient treated with TNF‐α inhibitor adalimumab for psoriasis-Reference-Cited by-同舟云学术

Erythematous plaques with zosteriform distribution in a patient treated with TNF‐α inhibitor adalimumab for psoriasis

Published:2021-06-17 Issue:11 Volume:60 Page:1366-1367
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Garcia‐Melendo Cristina¹,Cubiró Xavier¹,Tubau Carla¹,Mozos Anna²,Muñoz Carme³,Puig Lluís¹

Affiliation:

1. Department of Dermatology Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona Barcelona Spain

2. Department of Pathology Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona Barcelona Spain

3. Department of Microbiology Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona Barcelona Spain

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.15710

Reference6 articles.

1. Leishmaniasis cutánea zosteriforme causada por Leishmania (Viannia) panamensis y Leishmania (Viannia) braziliensis: reporte de tres casos;Morales CA;Biomédica,2014

2. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis.

3. Anti-Tumour Necrosis Factor-Induced Visceral and Cutaneous Leishmaniasis: Case Report and Review of the Literature

4. Anti‐tumour necrosis factor‐associated cutaneous leishmaniasis: a single‐institution experience

5. Cutaneous leishmaniasis associated with anti-tumour necrosis factor-α drugs: an emerging disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab;Reactions Weekly;2022-01